IMV-M

N/A

Report date: 2026/04/21 20:00:18

First In Class

Base Information

Drug NameIMV-M

Drug Alias NameIMV-M

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Mucin-16

TargetsMucin-16

Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmuVia Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmuVia Inc Quantori LLC

Inactive CompaniesN/A

Active IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A